---
title: "Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300338626.md"
description: "Cochlear announced the completion of recruitment for its worldwide pivotal trial program evaluating fully implantable hearing technology. Patients have accumulated over 1 million hours of device experience, reflecting a comprehensive research effort. The ELEVATE and ENTERPRISE studies in the US, Europe, and Australia have enrolled 92 patients. Cochlear emphasizes long-term commitment to this technology while advising current candidates not to delay existing treatments."
datetime: "2026-09-28T18:08:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300338626.md)
  - [en](https://longbridge.com/en/news/300338626.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300338626.md)
generator: "portal-rs"
---

# Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program

Cochlear, based in Sydney, has recently finished recruiting participants for its global pivotal trial assessing fully implantable hearing technology. Patients enrolled in Cochlear’s research programs have collectively logged over 1 million hours with the device. This milestone highlights the extensive research endeavors dedicated to fully implantable hearing technology, emphasizing Cochlear's unwavering dedication to advancing this innovative field. The program signals a significant step forward in enhancing hearing capabilities.

### Related Stocks

- [CHEOY.US](https://longbridge.com/en/quote/CHEOY.US.md)
- [COH.AU](https://longbridge.com/en/quote/COH.AU.md)

## Related News & Research

- [Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026](https://longbridge.com/en/news/302415256.md)
- [Cochlear completes recruitment for global pivotal trial of fully implantable hearing system](https://longbridge.com/en/news/300336857.md)
- [Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026](https://longbridge.com/en/news/301862137.md)
- [UBS Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/302231742.md)
- [Citi Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/298516761.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**